About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT05496530

Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)

Suprachoroidal drug delivery is a recent route for managing various ocular conditions. Safety and long term results are still under investigations.

Lead sponsor: Benha University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ahmed A Tabl

CONTACT

01222328766 ahmad4lg@gmail.com

Sponsors

Lead Sponsor

Benha University

In this study, we aim to analyze the long term results of suprachoroidal injection in treating various retinal diseases to focus on its efficacy, safety and long term ocular effects as ocular hypertension, cataract progression and macular edema resolution.

Age

30 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•cases with central macular thickness more than 250 microns measured by optical coherence tomography due to one of the following conditions:
•Diabetic macular edema
•Vogt-koyanagi Harada disease
•Retinal vein occlusion.

Exclusion Criteria

•other causes of increased macular thickness as age related macular degeneration and myopic choroidal new vascularization.
•Cases with confirmed diagnosis of glaucoma.

Related studies

National Eye Institute Biorepository for Retinal Diseases

NCT01496625 · Age-Related Macular Degeneration, Diabetic Retinopathy, and more

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

NCT07425522 · Diabetic Macular Edema

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)

Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

NCT07520045 · Diabetic Retinopathy (DR), Diabetic Macular Edema (DME)

RECRUITINGPhase 3

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

NCT07449936 · Diabetic Macular Edema, DME, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 11, 2022Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment100

Start dateJul 2022

Last updatedAug 11, 2022

Condition

Diabetic Macular Edema Vogt Koyanagi Harada Disease Retinal Vein Occlusion

Locations shown

Ahmed Abdelshafy Tabl

Banhā, Benha

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 11, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions